Publications

  1. Brewer LC, Hayes SN, Parker MW, Balls-Berry JE, Halyard MY, Pinn VW, Breitkopf CR. African American Women's Perceptions and Attitudes Regarding Participation in Medical Research: The Mayo Clinic/The Links, Incorporated Partnership. J Womens Health (Larchmt). 2014 Aug; 23(8):681-7. Epub 2014 Jul 21.
    View PubMed
  2. Halyard MY. From out of the desert blooms a jewel of the southwest: a commentary on the history of Mayo Clinic in Arizona. Mayo Clin Proc. 2014 Jul; 89(7):873-7.
    View PubMed
  3. Sloan J, Gowan M, Hubbard J, Halyard M, Sloan E. Incorporating validated measures for patient-reported outcomes in clinical practice. Proceedings of the Abu Dhabi Conference. March 2014.
  4. Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE. Six-year Outcome of a Prospective Study Evaluating Tumor Bed Boost with Intra-operative Electron Irradiation Followed by whole-Breast Irradiation for Early-Stage Breast Cancer. Breast J. 2014 Mar; 20(2):125-30. Epub 2013 Dec 26.
    View PubMed
  5. Patel SH, Hinni ML, Hayden RE, Wong WW, Dueck AC, Zarka MA, Curtis KK, Halyard MY. Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience. Head Neck. 2014 Feb; 36(2):220-5. Epub 2013 Mar 26
    View PubMed
  6. Patel SH, Munson ND, Grant DG, Buskirk SJ, Hinni ML, Perry WC, Foote RL, McNeil RB, Halyard MY. Relapse patterns after transoral laser microsurgery and postoperative irradiation for squamous cell carcinomas of the tonsil and tongue base. Ann Otol Rhinol Laryngol. 2014 Jan; 123(1):32-9.
    View PubMed
  7. Eton DT, Beebe TJ, Hagen PT, Halyard MY, Montori VM, Naessens JM, Sloan JA, Thompson CA, Wood DL. Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic. Patient Relat Outcome Meas. 2014; 5:7-15. Epub 2014 Feb 10.
    View PubMed
  8. Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai TH, Stien KJ, Martenson JA Jr. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013 Apr; 21(4):1193-9. Epub 2012 Nov 15.
    View PubMed
  9. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, Jakub JW, Roenigk RK, Brewer JD, Weaver AL, Otley CC. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013 Mar; 68(3):425-32. Epub 2012 Nov 27.
    View PubMed
  10. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Weaver AL, Roenigk RK, Brewer JD, Otley CC. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol. 2013 Mar; 68(3):433-40. Epub 2012 Nov 19.
    View PubMed
  11. Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012 Oct; 21(8):1305-14. Epub 2011 Nov 3
    View PubMed
  12. Halyard MY, Wasif N, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Horst KC, Moran MS, MacDonald SM, Haffty BG, Expert Panel on Radiation Oncology-Breast:. ACR Appropriateness Criteria(R) local-regional recurrence (LR) and salvage surgery: breast cancer. Am J Clin Oncol. 2012 Apr; 35(2):178-82.
    View PubMed
  13. Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG, American College of Radiology Breast Expert Panel. ACR appropriateness criteria((R)) ductal carcinoma in situ. Breast J. 2012 Jan-Feb; 18(1):8-15. Epub 2011 Nov 23.
    View PubMed
  14. Macdonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, Haffty BG. ACR appropriateness criteria(R) locally advanced breast cancer. Breast J. 2011 Nov-Dec; 17(6):579-85. Epub 2011 Sep 12.
    View PubMed
  15. Halyard MY. The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):561-70.
    View PubMed
  16. Peters DE, Halyard MY, Casale SA, Mayer AP, Viggiano TR. Effectively Integrating Medical Staff into a Multispecialty Group Practice: Results from Mayo Clinic. American Medical Group Association - Group Practice Journal. 2011 Oct.
  17. Bellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG, American College of Radiology. ACR Appropriateness Criteria(R) conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast. Breast J. 2011 Sep-Oct; 17(5):448-55. Epub 2011 Jul 25.
    View PubMed
  18. Moran MS, Harrison XB, Harris EER, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR Appropriateness Criteria: Ductal Carcinoma in Situ. The Breast Journal. 2011:1-8.
  19. Shi Q, Cleeland CS, Klepstad P, Miaskowski C, Pedersen NL, GeneQOL Consortium. Biological pathways and genetic variables involved in pain. Qual Life Res. 2010 Dec; 19(10):1407-17. Epub 2010 Sep 15
    View PubMed
  20. Sprangers MA, Sloan JA, Barsevick A, Chauhan C, Dueck AC, Raat H, Shi Q, Van Noorden CJ, GENEQOL Consortium. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res. 2010 Dec; 19(10):1395-403. Epub 2010 Oct 14.
    View PubMed
  21. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, GENEQOL Consortium. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 2010 Dec; 19(10):1419-27. Epub 2010 Oct 16.
    View PubMed
  22. Sprangers MAG, Bartels M, Veenhoven R, Baas F, Martin NG, Mosing M, Movsas B, Ropka ME, Shinozaki G, Swaab D, The GENEQOL Consortium. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Qual Life Res. 2010 Apr 24. [Epub ahead of print]
  23. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol. 2009 Jun 1; 99(7):447-55.
    View PubMed
  24. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol. 2009 Jun 1; 27(16):2638-44. Epub 2009 Apr 06.
    View PubMed
  25. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11.
    View PubMed
  26. Tondato F, Ng DW, Srivathsan K, Altemose GT, Halyard MY, Scott LR. Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction. Expert Rev Med Devices. 2009 May; 6(3):243-9.
    View PubMed
  27. Halyard M, Pisansky T, Dueck A, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil S, Perez E. Radiotherapy and Adjuvant Trastuzumab in Stage I-IIA Breast Cancer: Tolerability and Adverse Event Data From the North Central Cancer Treatment Group Phase I Trial N9831. J Clin Oncol. 2009; 27:2638-44.
    View PubMed
  28. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02.
    View PubMed
  29. Carpenter S, Fraser J, Fleming M, Gray R, Halyard M, Pockaj B. Optimal treatment of multiple ipsilateral primary breast cancers. Am J Surg. 2008 Oct; 196(4):530-6.
    View PubMed
  30. Halyard MY, Ferrans CE. Quality-of-Life assessment for routine oncology clinical practice. J Support Oncol. 2008 May-Jun; 6(5):221-9, 233.
    View PubMed
  31. Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T, Parada A, Alonso J. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008 Mar; 17(2):179-93. Epub 2008 Jan 04.
    View PubMed
  32. Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcome instrument selection: designing a measurement strategy. Value Health. 2007 Nov-Dec; 10 Suppl 2:S76-85.
    View PubMed
  33. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10(Suppl 2):S59-63.
    View PubMed
  34. Guyatt GH, Ferrans CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG, Kotzeva A, Valderas JM, Alonso JL, Clinical Significance Consensus Meeting Group. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc. 2007 Oct; 82(10):1229-39.
    View PubMed
  35. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
    View PubMed
  36. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22.
    View PubMed
  37. Snyder CF, Watson ME, Jackson ME, Cella D, Halyard MY. Patient-Reported Outcome Instrument Selection: Designing a Measurement Strategy. The Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group Val Health. 2007; 10:S76-S85.
  38. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QOL data really any different than other medical testing? Curr Probl Cancer. 2006 Nov-Dec; 30(6):261-71.
    View PubMed
  39. Halyard MY, Frost MH, Dueck A. Integrating QOL assessments for clinical and research purposes. Curr Probl Cancer. 2006 Nov-Dec; 30(6):319-30.
    View PubMed
  40. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer. 2006 Oct; 14(10):988-98. Epub 2006 Jun 23.
    View PubMed
  41. Halyard M, Sloan J. Applying QOL Assessments: Are solutions for QOL different than other medical testing? Curr Probl Cancer. 2006.
  42. Brown PD, Foote RL, McLaughlin MP, Halyard MY, Ballman KV, Collie AC, Miller RC, Flemming KD, Hallett JW. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5):1361-7. Epub 2005 Sep 19.
    View PubMed
  43. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc. 2005 Nov; 80(11):1480-4.
    View PubMed
  44. Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol. 2005 Nov-Dec; 3(6):399-408.
    View PubMed
  45. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7.
    View PubMed
  46. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9.
    View PubMed
  47. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients, with previous implant breast augmentation. Am J Surg. 2004 Aug; 188(2):122-5.
    View PubMed
  48. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27(4):389-94.
    View PubMed
  49. Halyard MY, McElrath MF, Abbott DL, Bour TC, Anderson JA. Building values from the ground up: the opening of the Mayo Clinic Hospital: building a workforce that fosters the organizational culture. Group Pract J. 2003; 52(9):9-11.
    View PubMed
  50. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):729-34.
    View PubMed
  51. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002 May; 80(1):19-25; discussion 26.
    View PubMed
  52. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002 Mar 15; 20(6):1578-83.
    View PubMed
  53. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S. Novotny PJ, Rumman TA. Phase III evaluation of fluoxetine for treatment of hot flashes J Clin Oncol. 2002; 20(6):1578-83.
  54. Schomberg PJ, Shanahan TG, Ingle JN, Donohue JH, Kuske RR, Sternfeld WC, Wold L, Cha SS, Petersen IA, Brindle JS, Halyard MY, Bollinger JW, Hawkins R, Pisansky TM. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study. Radiology. 1997 Feb; 202(2):565-9.
    View PubMed
  55. Halyard MY, Camoriano JK, Culligan JA, Weiland LH, Allen MS, Pluth JR, Pairolero PC. Malignant fibrous histiocytoma of the lung. Report of four cases and review of the literature. Cancer. 1996 Dec 15; 78(12):2492-7.
    View PubMed
  56. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
  57. Halyard MY, Grado GL, Schomberg PJ, Weaver AL, Grant CS, Pisansky TM. Conservative therapy of breast cancer. The Mayo Clinic experience. Am J Clin Oncol. 1996 Oct; 19(5):445-50.
    View PubMed
  58. Halyard MY, Cornella JL, Grado GL, Rizzo NR. Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease. J Natl Med Assoc. 1996 Jun; 88(6):391-3.
    View PubMed
  59. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):535-41.
    View PubMed
  60. Pisansky TM, Halyard MY, Weaver AL, Donohue JH, Grado GL, Grant CS, Hartmann LC, Ingle JN, Schomberg PJ, Wold LE. Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc. 1994 Jun; 69(6):515-24.
    View PubMed
  61. Schamadan JL, Covalciuc MA, Halyard MY, Trump DS, Whysong GL. Cancer in professional firefighters. Arizona Study Commission Report. 1992 Feb.
  62. Tuckson WB, Goldson AL, Ashayeri E, Halyard M, DeWitty RL, Leffall LD. Intraoperative radiotherapy for patients with carcinoma of the pancreas: the Howard University Hospital experience 1978-1986. Ann Surg. 1988; 207:648-54.
    View PubMed
  63. Ashayeri E, Halyard M, Goldson AL, Cruz L, Nibhanupudy JR, DeWitty R, Galal F, Marquis B, Slaughter L, Landes F. The first simultaneous intraoperative hyperthermia and radiotherapy procedure: dog experiment and technique. J Natl Med Assoc. 1987 Jun; 79(6):619-24.
    View PubMed
  64. Collier-Manning JD, Ashayeri EA, Goldson AL, Halyard MY, et al. The use of intraoperative radiotherapy and external beam therapy in the management of desmoid tumors. J Nat Med Assoc. 1986; 78:893-5.